MR linac & MRIdian

We are the first to bring the MRIdian to the UK – the latest in precision radiotherapy for many cancers

Cancer treatment that takes days not weeks

Technology that targets moving tumours

We offer cutting-edge, innovative cancer treatments to provide safe and effective care for our patients. We’re proud to be the first independent healthcare provider in the UK to introduce the MRIdian – an advanced MR linac. This world-class radiotherapy system is available at our centres in Oxford and Cromwell Hospital in London and can be accessed by patients throughout the UK.

MR linac technology combines high resolution magnetic resonance imaging (MRI) scanning techniques with extremely powerful radiotherapy beams to treat tumours more accurately than conventional radiotherapy. This type of radiotherapy is called magnetic resonance image guided radiotherapy (MRIgRT).

The benefits of MRIdian

Accurate targeting

Real-time magnetic resonance imaging(MRI) means the MRIdian can show the exact position and shape of the tumour during treatment, so it can target radiation at the tumour precisely

Greater control and precision

The MRIdian is the only MR linac to have automated beam control, so if your tumour moves slightly, your treatment will automatically pause until it comes back into position

Reduced side effects

The MRIdian’s increased accuracy means the radiation beam is less likely to damage healthy tissue than conventional radiotherapy. Side effects occur when healthy tissue is damaged

Fewer treatments

With conventional radiotherapy, you may need up to 37 treatments. But with the MRIdian, the radiation is much more focused and you may only need five treatments

Who can benefit from the MRIdian?

More than 10,000 people worldwide have already benefitted from having been treated with the MRIdian. It is a promising treatment option for tumours near other major organs where limiting damage to healthy tissue is paramount or in organs that move a lot, for example, due to breathing. This makes the MRIdian suitable for: 

Enquire now about the MRIdian

The MRIdian is available at our centres in Oxford and Cromwell Hospital in London. Your cancer specialist can refer you for a consultation. We’re recognised by all major insurers and we’ll help you with transport depending on treatment and locations, when required.
Enquire now

What does MRIdian treatment involve?

Here is an outline of what to expect after your initial consultation and before, during and after your treatment. There are four stages to the process: simulation, planning, treatment and follow-up. Before your first appointment, your care team will call you to explain any preparation instructions you may need to follow in advance of your appointments and to answer any questions you may have. 

This appointment will last for two to three hours and will involve a magnetic resonance imaging (MRI) scan on the MRIdian and a separate computerised tomography (CT) scan. It will involve the following steps: 

  1. Your radiographer will explain the process to you and ask you to fill in a safety questionnaire. 
  2. You will be asked to change into a gown and remove any metal objects such as jewellery, hair clips, hearing aids, glasses or dentures. 
  3. In the treatment room, you’ll be asked to lie on a couch where you will be placed in position. 
  4. Soft pads will be placed over the area of your body being treated. These pads, called coils, help to produce high quality MRI images. 
  5. We will fit you with earphones before your scan so you can listen to music (rather than the noise of the scanner). During the scan, which will last for around 20-30 minutes, you’ll be able to speak to the scanning team through an intercom. 
  6. Your CT scan will be in a different room and is much quicker, lasting around 5-10 minutes. You will be placed in the same position as for your MRI scan. 
  7. You can go home directly after your scans. 

Over the next week or so, your consultant and care team will work together to create a MRIdian radiotherapy plan that is specific to you. You do not need to attend your GenesisCare Centre during this process as we use advanced computer technology to create your MRIdian radiotherapy plan.

Your treatment will take 45-60 minutes. We will talk to you through our intercom system regularly throughout your treatment and you can talk to us.

Before each treatment session, you’ll have a new MRI scan, which will be compared with your planning scans. Any movements of your tumour and internal organs will be taken into account and your treatment plan will be carefully adjusted and optimised to account for these changes. Sometimes you may feel the couch that you are lying on move slightly; this is just the treatment team placing you in the perfect position for your treatment.

You can go straight home after each treatment session. You’ll be given contact details for your care team so you can call if you’re worried about anything.

After your treatment course has finished, you will be referred back to your own doctor, together with all the information they need to plan any further treatment you need.

Seven to 10 days later: a member of your care team will call to see how you are feeling and answer any questions you may have

Four to six weeks later: you’ll attend a review with your consultant.

Long-term, we will continue to follow-up your recovery and wellbeing through doctor appointments, phone calls and mobile apps.

Side effects of MRIdian

With the MRIdian, side effects can be fewer and less prolonged* than with conventional radiotherapy.

Our MRIdian specialists

Your treatment will be provided by one of our leading consultants who are all specially trained to provide radiotherapy using the MRIdian. They’ll work with a team of consultants who are also experts in this kind of advanced radiotherapy to review your referral and create a personalised treatment plan tailored to your needs.

Dr Rob Owens

Clinical Oncologist

Oxford

Special clinical interest in colorectal, hepato-pancreato-biliary and gastrointestinal cancers.

Dr Alex Martin

Clinical Oncologist

Cambridge, London

Special clinical interest in thoracic cancers and urological cancers.

Dr James Good

Clinical Oncologist

Birmingham, Oxford

Special clinical interest in colorectal, hepato-pancreato-biliary, and head and neck cancers.

Dr Kasia Owczarczyk

Clinical Oncologist

London

Special clinical interest in upper and lower gastrointestinal and hepato-pancreato-biliary cancers.

Dr Timothy Sevitt

Clinical Oncologist

Maidstone, London

Special clinical interest in lung and gastrointestinal cancers.

Prof Somnath Mukherjee

Clinical Oncologist

Oxford

Special clinical interest in gastrointestinal cancers and cancer research.

Dr Sherif Raouf

Clinical Oncologist

Chelmsford, London

Special clinical interest in upper and lower gastrointestinal, head and neck cancers.

Dr Sara Khaksar

Clinical Oncologist

London, Guildford

Special clinical interest in urological cancers and brochytherapy.

Dr Andy Gaya

Clinical Oncologist

London, Maidstone, Oxford

Special clinical interest in upper and lower, gastrointestinal and hepato-pancreato-biliary cancers.

Dr John Conibear

Clinical Oncologist

Chelmsford, London

Special clinical interest in thoracic cancers and breast cancers.

Dr Nicola Dallas

Clinical Oncologist

Oxford, Windsor

Special clinical interest in urological cancers, head and neck and thyroid cancer.

Dr Ami Sabharwal

Clinical Oncologist

Oxford

Special clinical interest in urological cancers and head and neck cancers.

Dr Prantik Das

Clinical Oncologist

Nottingham, Oxford

Special clinical interest in urological cancers, bladder, stomach, neuroendocrine and lung.

Dr Veni Ezhil

Clinical Oncologist

London, Guildford, Oxford

Special clinical interest in thoracic cancers and lymphoma.

Dr Carla Perna

Clinical Oncologist

London, Guildford, Oxford

Special clinical interest in urological cancers and brochytherapy.

Dr Nicola Anyamene

Clinical Oncologist

Elstree, London

Special clinical interest in upper gastrointestinal, urological and colorectal cancers.

Dr Alison Falconer

Clinical Oncologist

London

Special clinical interest in prostate, genitourinary cancers and brain and spine cancers.

Dr Joss Adams

Clinical Oncologist

Oxford, Windsor

Special clinical interest in lung and breast cancers.

Dr Dan Ford

Clinical Oncologist

Birmingham

Special clinical interest in urological cancers.

Dr Philip Camilleri

Clinical Oncologist

Milton Keynes, Oxford

Special clinical interest in urological cancers.

Dr Rafiqul Islam

Clinical Oncologist

Chelmsford, London

Special clinical interest in colorectal cancer, lung cancer and cancer of the unknown primary (CUP).

1 of 21

GenesisCare_CAP

Compassionate access for pancreatic cancer

Thanks to the GenesisCare Foundation, Pancreatic Cancer Research Fund and ViewRay, we are funding ground-breaking MRIdian treatment for eligible NHS patients
Read more

Find your nearest centre

#firstLevel=491&secondLevel=799-302

Search for a centre near you

Multiple selected